239 related articles for article (PubMed ID: 7589406)
1. Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.
Chung KF
Eur Respir J; 1995 Jul; 8(7):1203-13. PubMed ID: 7589406
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
3. Leukotrienes and their antagonists in allergic disorders.
Negro JM; Miralles JC; Ortiz JL; Funes E; García A
Allergol Immunopathol (Madr); 1997; 25(2):104-12. PubMed ID: 9150842
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
6. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonists and related compounds.
Wenzel SE
Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
[TBL] [Abstract][Full Text] [Related]
8. Antileukotriene treatment in children with asthma--new patents.
Stelmach I; Grzelewski T
Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene modifiers as novel therapeutics in asthma.
Leff JA
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():147-53; discussion 171-3. PubMed ID: 9988461
[TBL] [Abstract][Full Text] [Related]
10. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
Liu MC; Dubé LM; Lancaster J
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW
Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
[TBL] [Abstract][Full Text] [Related]
13. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
16. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
17. Antileukotriene agents.
Tan RA; Spector SL
Curr Opin Pulm Med; 1997 May; 3(3):215-20. PubMed ID: 9232368
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
19. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
20. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]